Table 2.
Demographics and Characteristic of the Studies.
| Author | Country | Level of Evidence | Participants, n | Mean Age, y | Feet, n | Women, n | Follow-up, mo | Control Group | Osteotomy |
|---|---|---|---|---|---|---|---|---|---|
| Burg et al3 | Israel | III | 20 | 66 | 21 | 17 | 12 | No | Chevron-Akin |
| Holme et al14 | England | IV | 40 | 51 | 40 | 38 | 12 | No | Chevron-Akin |
| Chan et al4 | Singapore | IV | 8 | 50.7 | 13 | 5 | 35 | No | Chevron-Akin |
| Liszka and Gądek21 | Poland | III | 54 | 54.5 | 103 | 97 | 12 | No | Chevron-Akin |
| de Carvalho et al5 | USA | IV | 47 | 55.9 | 70 | 39 | 31.6 | No | Chevron-Akin |
| Díaz Fernández6 | Spain | IV | 24 | 59 | 24 | 24 | 24 | No | RI, DMMO’s, Akin |
| Tay et al35 | Singapore | III | 60 (30 MIS) | 51.7 (MIS) | 60 (30 MIS) | 47 (21 MIS) | 24 | Yes | Chevron-Akin |
| Brogan et al2 | England | III | 81 (49 MIS) | 53 (MIS) | 81 (49 MIS) | 78 (46 MIS) | 24 | Yes | Chevron-Akin |
| Jowett and Bedi16 | Australia | IV | 78 | 55 | 106 | 76 | 25 | No | Chevron-Akin |
| Mikhail et al27 | USA | III | 248 | 55.1 | 274 | 218 | 12.9 | No | Chevron-Akin |
| Lai et al20 | Singapore | III | 87 (29 MIS) | 54.3 (MIS) | 87 (29 MIS) | 77 (25 MIS) | 24 | Yes | Chevron-Akin |
| Frigg et al9 | Switzerland | II | 98 (48 MIS) | 48 (MIS) | 98 (48 MIS) | 85 (41 MIS) | 24 | Yes | Chevron-Akin |
| Nunes et al29 | Brazil | IV | 40 | 50.4 | 50 | 37 | 16.1 | No | Chevron-Akin |
| Ghioldi et al10 | Argentina | III | 46 | 53.9 | 60 | 41 | 33.5 | No | Bösch |
| Kurashige17 | Japan | IV | 40 | 59.9 | 40 | 34 | 18.6 | No | Chevron-Akin |
| Marijuschkin et al24 | Brazil | IV | 72 | 58.8 | 112 (86 MIS) | 64 | 17.2 | No | Akin, chevron, RI |
| Lucas y Hernandez et al23 | France | III | 38 | 48 | 45 | 35 | 59.1 | No | R-L-chevron |
Abbreviations: DMMOs, distal metatarsal minimally invasive osteotomies; MIS, minimally invasive surgery; RI, Reverdin-Isham; R-L-chevron, reverse-L-chevron.